Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewImmunology Open Access | 10.1172/jci.insight.201920

A universal platform for TCRα/β removal enables safer and more potent TCR therapies and autoimmune modeling

Giorgia Zanetti,1 Sameena Nikhat,2 Mateusz Legut,3 Austin Chen,1 Farshid Fathi,1 Nathan Suek,1 Nato Teteloshvili,1 Hao Wei Li,1 Xiaolan Ding,1 Daniel Traum,4 Klaus H. Kaestner,4 Ryan E. Hoang,6 Andrew K. Sewell,7 Audrey V. Parent,6 Remi J. Creusot,1 Megan Sykes,1 and Mohsen Khosravi-Maharlooei1

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Zanetti, G. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Nikhat, S. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Legut, M. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Chen, A. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Fathi, F. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Suek, N. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Teteloshvili, N. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Li, H. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Ding, X. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Traum, D. in: PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Kaestner, K. in: PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Hoang, R. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Sewell, A. in: PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Parent, A. in: PubMed | Google Scholar

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Creusot, R. in: PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Sykes, M. in: PubMed | Google Scholar |

1Columbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, Columbia University, New York, United States of America

2Department of Immunology, Mayo Clinic, Phoenix, United States of America

3OverT Bio, New York, United States of America

4Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States of America

5Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Perelman School of Medicine, Philadeplhia, United States of America

6Diabetes Center, UCSF, San Francisco, United States of America

7Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom

Find articles by Khosravi-Maharlooei, M. in: PubMed | Google Scholar

Published November 17, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.201920.
Copyright © 2026, Zanetti et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published November 17, 2026 - Version history
View PDF
Abstract

Adoptive T-cell therapies using tumour-specific T-cell receptors (TCRs) are limited by competition with endogenous receptors, impairing efficacy and posing risks of off-target autoreactivity. Here we present a CRISPR-based platform that selectively eliminates both endogenous TCR-α and -β chains without affecting transgenic TCRs, irrespective of codon optimization. This approach achieves >90% deletion efficiency in Jurkat and primary human T cells, enhancing expression and functional potency of transgenic receptors. Using an HLA-A*02:01-restricted DMF5 TCR, we show that dual TCR ablation boosts antigen-specific activation and cytotoxicity in vitro and enhances tumor clearance in vivo in human immune system (HIS) mice and prevents graft-versus-host disease (GVHD). Targeted locus amplification showed that CRISPR-induced double-strand breaks did not alter lentiviral integration profiles, supporting genomic safety. Extending this approach to four insulin-reactive TCRs demonstrated that endogenous receptor removal increased transduction efficiency and functional activity, with one (1E6) showing selective activation and infiltration of islet grafts (SC-islets) in vivo. This study establishes a universal, safe, and scalable genome-editing platform for generating functionally precise human T cells. By integrating cancer immunotherapy and autoimmune disease modelling within a single framework, it provides a preclinical rationale for dual endogenous TCR removal to improve specificity, safety, and therapeutic efficacy in TCR-based cell therapies.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View Supplemental data in word

View

Version history
  • Version 1 (November 17, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts